The role of etoposide in the treatment of adult patients with hemophagocytic lymphohistiocytosis.

导出 OA

翻译打印收藏纠错

第一作者： Timo C E,Zondag

第一单位： Department of Internal Medicine, Clinical Immunology Section, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.

作者： Timo C E,Zondag ^[1] ; Aglina,Lika ^[2] ; Jan A M,van Laar ^[3]

作者单位： Department of Internal Medicine, Clinical Immunology Section, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. ^[1] Department of Biostatistics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.;Department of Pediatrics, Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.;Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. ^[2] Department of Internal Medicine, Clinical Immunology Section, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. j.vanlaar@erasmusmc.nl.;Department of Immunology, Clinical Immunology Section, Erasmus University Medical Center, Rotterdam, The Netherlands. j.vanlaar@erasmusmc.nl. ^[3]

关键词 Etoposide HLH-94 criterion Hemophagocytic lymphohistiocytosis Histiocytic disorder Immuno-chemotherapy Meta-analysis Systematic review

DOI 10.1186/s40164-022-00362-2

PMID 36624539

发布时间 2023-01-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交